Reneker Lixing W, Chen Qin, Bloch Amy, Xie Leike, Schuster Gaby, Overbeek Paul A
Department of Ophthalmology, University of Missouri, Columbia, 65212, USA.
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4083-90. doi: 10.1167/iovs.03-1270.
Both the -366/+43 and the -282/+43 mouse alphaA-crystallin (or alphaA) promoters have been effective at driving transgene expression in lens fiber cells, but not in lens epithelium. Because the chick delta1-crystallin gene is expressed in lens epithelial cells, an enhancer was borrowed from this gene and linked to the alphaA promoter. This heterogenic enhancer/promoter construct was tested in transgenic mice to see whether it was active in both lens epithelium and fiber cells while retaining lens specificity.
The third intron of the chick delta1-crystallin gene, which contains a lens enhancer element, was added to the 5' end of the mouse alphaA promoter. We refer to this chimeric regulatory element as the deltaenalphaA promoter. To test its activity, we inserted coding sequences for five different genes. Transgenic mice were generated by pronuclear microinjection. Transgene expression patterns were analyzed by either X-gal staining, in situ hybridization or immunohistochemical staining.
When deltaenalphaA-lacZ transgenic embryos were stained with X-gal at embryonic day (E)11.5, beta-galactosidase activity was detected only in the eye. Histologic sections of the stained embryos revealed that lacZ was expressed exclusively in the lens, in both epithelial and fiber cells. Transgenic mice were also generated using either the original alphaA- or the new deltaenalphaA promoter linked to an insulin cDNA. In situ hybridizations confirmed that the short alphaA promoter targeted prenatal insulin expression specifically to the lens fiber cells, whereas the deltaenalphaA promoter was active in both lens epithelial and fiber cells. Developmental studies of the deltaenalphaA-insulin mice showed that the deltaenalphaA promoter became active at the lens pit stage and remained active in all lens cells, even at postnatal ages. The deltaenalphaA promoter also successfully directed expression of SV40 T-antigen (TAg), human E2F2, and dominant negative Sprouty2 (dn-Spry2) genes to lens epithelial and fiber cells. The lens specificity of the deltaenalphaA promoter was maintained in minigenes with different types of introns and polyadenylation signals.
A new lens-specific regulatory element was generated-the deltaenalphaA promoter, which can drive high levels of transgene expression in both lens epithelium and fiber cells throughout development. This modified promoter can be used for future transgenic studies of signal transduction and cell cycle regulation in lens epithelial cells.
-366/+43和-282/+43小鼠αA-晶体蛋白(或αA)启动子在驱动转基因在晶状体纤维细胞中表达方面有效,但在晶状体上皮细胞中无效。由于鸡δ1-晶体蛋白基因在晶状体上皮细胞中表达,因此从该基因借用一个增强子并与αA启动子相连。在转基因小鼠中测试这种异源增强子/启动子构建体,以观察其在晶状体上皮细胞和纤维细胞中是否具有活性,同时保持晶状体特异性。
将含有晶状体增强子元件的鸡δ1-晶体蛋白基因的第三个内含子添加到小鼠αA启动子的5'端。我们将这种嵌合调节元件称为δenαA启动子。为了测试其活性,我们插入了五个不同基因的编码序列。通过原核显微注射产生转基因小鼠。通过X-gal染色、原位杂交或免疫组织化学染色分析转基因表达模式。
当在胚胎第(E)11.5天用X-gal对δenαA-lacZ转基因胚胎进行染色时,仅在眼睛中检测到β-半乳糖苷酶活性。染色胚胎的组织学切片显示,lacZ仅在晶状体的上皮细胞和纤维细胞中表达。还使用与胰岛素cDNA相连的原始αA启动子或新的δenαA启动子产生了转基因小鼠。原位杂交证实,短αA启动子将产前胰岛素表达特异性靶向晶状体纤维细胞,而δenαA启动子在晶状体上皮细胞和纤维细胞中均有活性。对δenαA-胰岛素小鼠的发育研究表明,δenαA启动子在晶状体窝阶段开始活跃,并在所有晶状体细胞中保持活跃,甚至在出生后阶段也是如此。δenαA启动子还成功地将SV40 T抗原(TAg)、人E2F2和显性负性Sprouty2(dn-Spry2)基因的表达导向晶状体上皮细胞和纤维细胞。δenαA启动子的晶状体特异性在具有不同类型内含子和多聚腺苷酸化信号的小基因中得以维持。
产生了一种新的晶状体特异性调节元件——δenαA启动子,它可以在整个发育过程中驱动转基因在晶状体上皮细胞和纤维细胞中高水平表达。这种修饰的启动子可用于未来对晶状体上皮细胞中信号转导和细胞周期调控的转基因研究。